Icatibant Accord Unione Europea - italiano - EMA (European Medicines Agency)

icatibant accord

accord healthcare s.l.u. - icatibant acetate - angioedema, ereditario - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.

Icatibant Xiromed 30 mg 10 mg/ml, Injektionslösung in einer Fertigspritze Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

icatibant xiromed 30 mg 10 mg/ml, injektionslösung in einer fertigspritze

xiromed sa - icatibantum - 10 mg/ml, injektionslösung in einer fertigspritze - icatibantum 30 mg ut icatibanti acetas, natrii chloridum, acidum aceticum glaciale, natrii hydroxidum, aqua ad iniectabile, q.s. ad solutionem pro 3 ml corresp. natrium 9.9 mg. - trattamento di angioedema (treatment of angioedema) - synthetika

ICATIBANT HIKMA Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

icatibant hikma

hikma farmaceutica (portugal) s.a. - icatibant - icatibant

ICATIBANT PIRAMAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

icatibant piramal

piramal critical care italia s.p.a. - icatibant - icatibant

ICATIBANT FRESENIUS Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

icatibant fresenius

fresenius kabi italia s.r.l. - icatibant - icatibant